Home
Inside Ensoma
Our Science
Pipeline
Careers
News
Contact
Ensoma
Inside Ensoma
About Us
Leadership
Board of Directors
Scientific Advisors
Investors
Our Science
Pipeline
Careers
News
Press Releases
Presentations
Publications
In the News
Contact
Curative medicines through precision
in vivo
cellular engineering
Post navigation
Next:
In vivo VLP-based engineering generates multi-lineage CAR-immune cells that mediate potent and durable anti-tumor activity